Product Information
MINZOYA-28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $3.4454 per EA under NDC 70748032214. Its NADAC has been published 82 times since Mar 12, 2025.
FDA first approved this application on Feb 15, 2024. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748032214
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA217087FDA Approved
2/15/2024
TE Code
AB3
On Market Since
1/9/2025
Price Statistics
The NADAC for MINZOYA-28 TABLET has been published 82 times since Mar 12, 2025, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4454 per EA |
|---|---|
| All-time high | $5.8495 (May 14, 2025) |
| All-time low | $3.4240 (Jul 22, 2026) |
| 52-week high | $5.2252 |
| 52-week low | $3.4240 |
| Median price | $4.9444 |
| Average price | $4.8136 |
| Largest weekly change | -9.3% (May 20, 2026) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levonorgestrel and ethinyl estradiol and ferrous bisglycinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel and ethinyl estradiol and ferrous bisglycinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINZOYA-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINZOYA-28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $3.4454 per EA (NDC 70748032214), effective Sep 30, 2026.
How has the price of MINZOYA-28 TABLET changed over time?
Over the history we have for it, the NADAC for MINZOYA-28 TABLET has declined 36.6%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for MINZOYA-28 TABLET?
Since Mar 12, 2025, the NADAC for MINZOYA-28 TABLET has ranged from a low of $3.4240 (Jul 22, 2026) to a high of $5.8495 (May 14, 2025), with a median of $4.9444 per EA.
Are there cheaper alternatives to MINZOYA-28 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MINZOYA-28 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MINZOYA-28 TABLET?
MINZOYA-28 TABLET (NDC 70748032214) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.